Tesamorelin acetate is a synthetic form of growth hormone-releasing hormone (GHRH) that is primarily used to reduce abdominal fat in HIV-infected patients with lipodystrophy. Understanding the correct dosage is essential for achieving the desired therapeutic effects while minimizing side effects.
For detailed dosage guidelines and recommendations, you can refer to the following resource: https://www.perupesquero.org/tesamorelin-acetate-dosage-guidelines-and-recommendations.
Recommended Dosage
The standard dosing protocol for tesamorelin acetate involves the following:
- Standard Dosage: The typical starting dose is 2 mg administered subcutaneously once daily.
- Administration: It is recommended to administer the injection at the same time every day, preferably in the evening.
- Preserving Stability: The reconstituted solution should be used within 30 days if stored in a refrigerator.
Monitoring and Adjustment
Healthcare providers should monitor the patient’s response to the treatment and make dosage adjustments as needed. Factors that may necessitate a dosage change include:
- Changes in body composition.
- Side effects experienced by the patient.
- Overall health status of the patient.
As with any medication, it is vital for patients to follow their healthcare provider’s recommendations and consult them when considering any changes in dosage.